Altitude sickness typically begins at elevations above 8,000 feet (2,438 meters), though symptoms can emerge as low as 6,500 feet (1,981 meters) in sensitive individuals. It results from reduced oxygen availability at high altitudes, leading to impaired cellular function and systemic symptoms.
The condition arises when the body cannot acclimate quickly enough to lower atmospheric pressure and oxygen levels. At sea level, air contains approximately 21% oxygen, but at 8,000 feet, that concentration drops by nearly 25%. This reduction forces the body to compensate through increased breathing rate and heart rate. When adaptation lags, symptoms appear.
According to the Centers for Disease Control and Prevention (CDC), acute mountain sickness (AMS) affects up to 25% of people ascending to altitudes above 8,000 feet without proper acclimatization. The risk increases sharply between 8,000 and 12,000 feet, where oxygen saturation in blood can drop below 90% in unacclimated individuals.
As elevation rises, barometric pressure decreases. With less pressure, each breath delivers fewer oxygen molecules to the lungs. The brain detects this drop and signals faster breathing to compensate. Over time, the kidneys excrete more bicarbonate to balance blood pH, which helps maintain oxygen delivery.
Without gradual ascent, the body cannot adjust. Fluid may leak into the lungs (high-altitude pulmonary edema, HAPE) or brain (high-altitude cerebral edema, HACE), both life-threatening conditions. These complications usually develop within 24-72 hours of rapid ascent to altitudes above 8,000 feet.
A 2021 study published in *The Lancet* found that individuals who ascend more than 1,000 feet per day above 8,000 feet have a 40% higher incidence of AMS compared to those who ascend slowly. The study tracked 1,200 climbers in the Himalayas and concluded that pacing matters more than individual fitness.
Altitude sickness is not guaranteed at any specific height-it depends on ascent speed, individual physiology, and prior exposure. However, general thresholds exist:
| Altitude Range | Risk Level | Typical Onset Time | Common Symptoms |
|---|---|---|---|
| 6,500-8,000 ft (1,981-2,438 m) | Low to moderate | 2-6 hours | Headache, nausea, fatigue, dizziness |
| 8,000-12,000 ft (2,438-3,658 m) | Moderate to high | 6-24 hours | Worsening headache, vomiting, confusion, shortness of breath |
| 12,000-18,000 ft (3,658-5,486 m) | High | 24-48 hours | Severe confusion, ataxia, cyanosis, inability to walk |
Most cases of mild acute mountain sickness (AMS) occur between 8,000 and 10,000 feet. A 2019 survey by the American College of Sports Medicine reported that 60% of hikers experiencing AMS were between 8,500 and 10,000 feet during their first ascent.
Contrary to popular belief, altitude sickness is not limited to mountainous regions. Commercial aircraft fly at cabin pressures equivalent to 6,000-8,000 feet, which can trigger symptoms in susceptible passengers. If you're prone to altitude sickness, flying may cause headaches or fatigue upon descent.
Many mistake altitude sickness for dehydration, exhaustion, or motion sickness. Dehydration causes similar symptoms-headache, nausea-but lacks the progressive neurological signs seen in HACE. Exhaustion from physical exertion can mimic fatigue from hypoxia, but it resolves with rest rather than descent.
Another misconception is that altitude sickness only affects unfit people. The CDC clarifies that anyone can develop it regardless of fitness level. A 2020 case series from the University of Colorado Hospital documented five elite endurance athletes who developed severe AMS after ascending rapidly to 11,000 feet during a training expedition.
Even experienced mountaineers are vulnerable. In 2017, a climber with over 20 years of high-altitude experience required emergency evacuation from Mount Rainier due to HACE after reaching 10,500 feet in under six hours.
Gradual ascent is the most effective preventive measure. The CDC recommends no more than 1,000 feet of elevation gain per day above 8,000 feet, with a rest day every 3,000 feet. Staying hydrated, avoiding alcohol, and eating high-carbohydrate meals support acclimatization.
Medications such as acetazolamide (Diamox) reduce onset time by 50% in clinical trials. A 2018 double-blind study in *JAMA Internal Medicine* showed that 250 mg daily of acetazolamide cut AMS incidence by 44% in participants ascending to 10,000 feet.
If symptoms appear, stop ascending. Treat mild cases with rest, hydration, and over-the-counter pain relievers. Severe symptoms require immediate descent. HACE and HAPE demand emergency treatment-oxygen therapy and dexamethasone for HACE, nifedipine for HAPE.
I once guided a group of seven hikers to 11,000 feet in the Sierra Nevada. Two developed moderate AMS after skipping a rest day. We descended 1,500 feet overnight. By morning, both had full recovery. That experience reinforced that altitude illness respects no rank or experience level.
Any sign of confusion, loss of coordination, or persistent vomiting requires urgent evaluation. These indicate HACE or HAPE-conditions that progress rapidly and can be fatal within hours.
For travelers planning to fly to high-altitude destinations, consider using supplemental oxygen during flights. Airlines like Delta and United offer portable oxygen units for passengers with respiratory conditions, though they're not standard for altitude sickness prevention.
Understanding the threshold at which altitude sickness occurs-typically above 8,000 feet-helps prevent serious outcomes. Early recognition and prompt action remain critical for safety at high elevations.